Auxano Unveiled an Enhanced Platform Showcasing Osseointegration and Innovation in Bone-Implant Solutions
Auxano Medical, an innovative orthopedic implant company specializing in osseointegration and bone-implant interface technology, has unveiled a revamped website. The new platform enhances access for surgeons, distributors, and industry partners to crucial information about the company's unique surface morphology technology and its range of orthopedic implants, featuring standout products like the ARKEO™ Wedge Fixation System and the INTREPED® Intraosseous Fusion Device.

According to Precedence Research, the Implantable Sensor Orthopedic Market was valued at USD 1.06 billion in 2025 and is projected to grow from USD 3.06 billion in 2026 to approximately USD 13.17 billion by 2035, expanding at a CAGR of 17.40% from 2026 to 2035, driven by increasing adoption of advanced osseointegration.
Redesigned Platform Enhances Visibility
Auxano Medical has launched a redesigned website with a modern interface and streamlined navigation, reinforcing its mission to improve hard tissue integration through innovative implant design. The relaunch reflects the company’s continued growth in the foot and ankle orthopedic market. The updated platform provides surgeons, distributors, and industry partners with expanded access to information on Auxano® Medical’s proprietary surface morphology technology and implant portfolio, including the ARKEO™ Wedge Fixation System and INTREPED® Intraosseous Fusion Device. The new digital platform highlights Auxano® osseointegration technology, strengthens visibility for its growing implant offerings, and supports its position in the orthopedic implant sector.
Auxano Medical’s redesigned website adds expanded product information for the ARKEO™ Wedge Fixation System and INTREPED® Intraosseous Fusion Device, greater visibility into its proprietary surface morphology technology, a new education center with clinical research and technology resources, and improved mobile responsiveness and user experience. Developed by Cleveland-based Stream 9, the platform supports broader access to Auxano® Medical’s orthopedic technologies.
Auxano surface morphology technology is designed to promote continuous bone integration and optimized stress transfer at the bone-implant interface. INTREPED® features 3D-printed titanium architecture for minimally invasive midfoot arthrodesis, while ARKEO™ applies the technology to flatfoot deformity correction.
A recent report by Precedence Research highlights that the Implantable Sensor Orthopedic Market is benefiting from the rising demand for minimally invasive orthopedic procedures.